Linagliptin
3 NDCs across 1 manufacturer|0 Generic,3 Brand
Linagliptin is used to treat type 2 diabetes mellitus, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on May 2, 2011, and the first generic was approved Aug 31, 2021. FDA's Orange Book lists 9 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $1.1 billion on Linagliptin across 1.4 million claims for 275,000 beneficiaries.
Linagliptin is available as 3 NDCs from 1 manufacturer (0 generic, 3 brand), with NADAC prices from $16.80 to $16.80 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
3
0G / 3B
Manufacturers
1
competing in market
Price Spread
$16.80 – $16.80
per EA
7d Activity
avg -0.0% WoW · of 3 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing LINAGLIPTIN
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
TRADJENTA 5 MG TABLET | $16.7969 per EA | -0.03% |
TRADJENTA 5 MG TABLET | $16.7969 per EA | -0.03% |
TRADJENTA 5 MG TABLET | $16.7969 per EA | -0.03% |
Frequently Asked Questions
What is Linagliptin used to treat?
Linagliptin is used to treat type 2 diabetes mellitus, per the National Library of Medicine's MED-RT classification.
When did Linagliptin become available as a generic?
FDA approved the first generic Linagliptin (ANDA) on Aug 31, 2021. The Orange Book currently lists 9 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Linagliptin?
In 2024, Medicare Part D spent $1.1 billion on Linagliptin across 1.4 million claims for 275,000 beneficiaries.
How many Linagliptin products are on the market?
The Linagliptin drug market contains 3 NDCs from 1 manufacturer — 0 generic and 3 brand products.
What is the price range for Linagliptin?
NADAC reference prices for Linagliptin range from $16.7969 to $16.7969 per EA.
Which manufacturers make Linagliptin?
1 manufacturer lists Linagliptin in NADAC. Ranked by number of NDCs, the largest are Boehringer Ingelheim Pharmaceuticals Inc. (3).
How has the price of Linagliptin changed recently?
Over the past 7 days, 0 Linagliptin NDCs rose and 3 fell, with a market-wide average change of -0.0%.